行情

VRML

VRML

Vermillion
NASDAQ

实时行情|Nasdaq Last Sale

0.7980
-0.0120
-1.48%
交易中 14:22 04/02 EDT
开盘
0.7991
昨收
0.8100
最高
0.8200
最低
0.7710
成交量
7.11万
成交额
--
52周最高
1.570
52周最低
0.3506
市值
7,763.44万
市盈率(TTM)
-4.3726
分时
5日
1月
3月
1年
5年

分析师评级

1位分析师的综合评级

中性

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

目标价格预测

分析师预测VRML价格均价为1.000,最高价位1.000,最低价为1.000。

EPS

VRML 新闻

更多
  • 瑞幸称相关人员已停职并被接任 有员工准备另谋出路
  • 新浪财经综合 · 1小时前
  • “大空头”查诺斯:需对因疫情短暂受益的“病毒股”保持谨慎
  • 新浪美股 · 1小时前
  • Recode:亚马逊禁止商家向公众销售N95和医用外科口罩
  • 新浪美股 · 1小时前
  • 你需要了解:新冠病毒将重铸美国科技版图
  • 新浪财经综合 · 1小时前

所属板块

生物技术和医学研究
+0.51%
制药与医学研究
+0.62%

热门股票

代码
价格
涨跌幅

VRML 简况

Vermillion, Inc. is a diagnostic service and bio-analytic solutions provider. The Company is engaged in the business of developing and commercializing diagnostic tests for gynecologic disease. It sells OVA1 risk of malignancy test for pelvic mass disease (OVA1). OVA1 is a blood test designed to, in addition to a physician's clinical assessment of a woman with a pelvic mass, identify women who are at risk of having a malignant ovarian tumor prior to planned surgery. It developed OVA1 through pre-clinical studies in collaboration with various academic medical centers encompassing over 2,500 clinical samples. OVA1 is validated in a multi-center clinical trial encompassing approximately 30 sites reflective of the diverse nature of the clinical centers, at which ovarian adnexal masses are evaluated. Its ASPiRA LABS is a laboratory that provides diagnostic services using a biomarker-based diagnostic algorithm to inform clinical decision making and personalized treatment plans.
展开

微牛提供Vermillion, Inc.(NASDAQ-VRML)的股票价格,实时市场报价,专业分析师评级,深度图表和免费的VRML股票新闻,以帮助您做出投资决策。